Rogers offrira au Canada les produits Comcast et Xfinity de classe mondiale
Une nouvelle étude révèle que la majorité des Canadiennes et Canadiens se sent dépassée par le nombre de services et […]
Rogers to Bring World-Class Comcast and Xfinity Products to Canada
New research finds majority of Canadians say the number of streaming services and apps is overwhelming New entertainment service will […]
Vishay Intertechnology Automotive Grade IHDF Edge-Wound Inductor With Low 15.4 mm Max. Profile Delivers Saturation Current to 230 A
MALVERN, Pa., April 24, 2024 (GLOBE NEWSWIRE) — Vishay Intertechnology, Inc. (NYSE: VSH) today introduced a new Automotive Grade IHDF […]
Verizon readies for 2024 wildfire season
IRVINE, Calif., April 24, 2024 (GLOBE NEWSWIRE) — As Wildfire Awareness Month approaches in May, Verizon is committed to maintaining […]
Execution of Definitive Agreement to Acquire up to 67% of Giraffe Energy – Expansion of Orange Basin Platform in Namibia & Creation of Community Trust
TORONTO, April 24, 2024 (GLOBE NEWSWIRE) — Sintana Energy Inc. (TSX-V: SEI, OTCQB: SEUSF) (“Sintana” or the “Company”) is pleased […]
TSX News -
Xtract One Closes $7.2M Public Offering and $1.4M Investment by Strategic Partner
THIS NEWS RELEASE IS INTENDED FOR DISTRIBUTION IN CANADA ONLY AND IS NOT INTENDED FOR DISTRIBUTION TO UNITED STATES NEWSWIRE […]
Cullinan Therapeutics to Present Clinical Data from Phase 1 Study Evaluating Novel Anti-MICA/B Antibody, CLN-619, as Monotherapy and in Combination with a Checkpoint Inhibitor in Patients with Advanced Solid Tumors at ASCO 2024
CAMBRIDGE, Mass., April 24, 2024 (GLOBE NEWSWIRE) — Cullinan Therapeutics, Inc. (Nasdaq: CGEM), a biopharmaceutical company focused on modality-agnostic targeted […]
Regeneron to Showcase Progress in Advancing Novel Investigational Treatment Approaches for a Broad Range of Solid Tumors and Blood Cancers at ASCO
Oral presentation will feature new data for investigational REGN7075, an EGFRxCD28 costimulatory bispecific with the potential to enhance the treatment […]
TSX News -
Medicenna Announces Oral Presentation of MDNA11 Data from the Phase 1/2 ABILITY-1 Study at the 2024 ASCO Annual Meeting
Oral presentation of MDNA11’s Phase 1/2 ABILITY-1 Study will feature new and updated clinical data Updated bizaxofusp survival results from […]
Canon Solutions America’s University Inkjet Program Marks Five Years of Providing Students Real-World Experience
MELVILLE, N.Y., April 24, 2024 (GLOBE NEWSWIRE) — Providing real-world experience to complement classroom instruction can bring classroom learning to […]
